Gene Review:
MBNL1 - muscleblind-like splicing regulator 1
Homo sapiens
Synonyms:
EXP, EXP35, EXP40, EXP42, KIAA0428, ...
- MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. de Haro, M., Al-Ramahi, I., De Gouyon, B., Ukani, L., Rosa, A., Faustino, N.A., Ashizawa, T., Cooper, T.A., Botas, J. Hum. Mol. Genet. (2006)
- Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S., Thornton, C.A. Hum. Mol. Genet. (2006)
- Morphologic alterations of the proximal tubules in light chain-related renal disease. Sanders, P.W., Herrera, G.A., Lott, R.L., Galla, J.H. Kidney Int. (1988)
- CA 125 regression: a model for epithelial ovarian cancer response. Buller, R.E., Berman, M.L., Bloss, J.D., Manetta, A., DiSaia, P.J. Am. J. Obstet. Gynecol. (1991)
- The clinical use of external noninvasive pacing in the termination of sustained ventricular tachycardia. Grubb, B.P., Temesy-Armos, P., Hahn, H., Elliott, L. Pacing and clinical electrophysiology : PACE. (1990)
- Cognitive therapy versus exposure and applied relaxation in social phobia: A randomized controlled trial. Clark, D.M., Ehlers, A., Hackmann, A., McManus, F., Fennell, M., Grey, N., Waddington, L., Wild, J. Journal of consulting and clinical psychology. (2006)
- Safety and efficacy evaluation of a fitness club weight-loss program. Kaats, G.R., Keith, S.C., Pullin, D., Squires, W.G., Wise, J.A., Hesslink, R., Morin, R.J. Advances in therapy. (1998)
- RNA-dependent integrin alpha3 protein localization regulated by the Muscleblind-like protein MLP1. Adereth, Y., Dammai, V., Kose, N., Li, R., Hsu, T. Nat. Cell Biol. (2005)
- Muscleblind proteins regulate alternative splicing. Ho, T.H., Charlet-B, N., Poulos, M.G., Singh, G., Swanson, M.S., Cooper, T.A. EMBO J. (2004)
- Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. Miller, J.W., Urbinati, C.R., Teng-Umnuay, P., Stenberg, M.G., Byrne, B.J., Thornton, C.A., Swanson, M.S. EMBO J. (2000)
- Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure. Delclos, G.L., Flitcraft, D.G., Brousseau, K.P., Windsor, N.T., Nelson, D.L., Wilson, R.K., Lawrence, E.C. Environmental research. (1989)
- Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Kino, Y., Mori, D., Oma, Y., Takeshita, Y., Sasagawa, N., Ishiura, S. Hum. Mol. Genet. (2004)
- An interspecific functional complementation test in Drosophila for introductory genetics laboratory courses. Monferrer, L., Artero, R. J. Hered. (2006)
- The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Pascual, M., Vicente, M., Monferrer, L., Artero, R. Differentiation (2006)
- Cell surface receptors and ectoenzymes in mesangial cells. Ardaillou, R., Chansel, D., Stefanovic, V., Ardaillou, N. J. Am. Soc. Nephrol. (1992)
- Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. Ho, T.H., Savkur, R.S., Poulos, M.G., Mancini, M.A., Swanson, M.S., Cooper, T.A. J. Cell. Sci. (2005)
- In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Fardaei, M., Larkin, K., Brook, J.D., Hamshere, M.G. Nucleic Acids Res. (2001)
- The catabolic effects of prolonged inactivity and acute hypercortisolemia are offset by dietary supplementation. Paddon-Jones, D., Sheffield-Moore, M., Urban, R.J., Aarsland, A., Wolfe, R.R., Ferrando, A.A. J. Clin. Endocrinol. Metab. (2005)
- Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Morsing, P., Adler, G., Brandt-Eliasson, U., Karp, L., Ohlson, K., Renberg, L., Sjöquist, P.O., Abrahamsson, T. Hypertension (1999)
- Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers. Soldner, A., Benet, L.Z., Mutschler, E., Christians, U. Br. J. Pharmacol. (2000)
- Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Cardani, R., Mancinelli, E., Rotondo, G., Sansone, V., Meola, G. European journal of histochemistry : EJH. (2006)
- ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. Leroy, O., Dhaenens, C.M., Schraen-Maschke, S., Belarbi, K., Delacourte, A., Andreadis, A., Sablonnière, B., Buée, L., Sergeant, N., Caillet-Boudin, M.L. J. Neurosci. Res. (2006)
- Prediction of VO2peak from submaximal cycle ergometry using 50 versus 80 rpm. Swain, D.P., Wright, R.L. Medicine and science in sports and exercise. (1997)
- Effects of muscle electrical stimulation on peak VO2 in cardiac transplant patients. Vaquero, A.F., Chicharro, J.L., Gil, L., Ruiz, M.P., Sánchez, V., Lucía, A., Urrea, S., Gómez, M.A. International journal of sports medicine. (1998)
- Laser-assisted microvascular anastomosis of human adult and placental arteries with expanded polytetrafluoroethylene microconduit. Bentz, M.L., Parva, B., Dickson, C.S., Futrell, J.W., Johnson, P.C. Plast. Reconstr. Surg. (1993)